Are BPC-157 and TB-500 chemically related?

No. They belong to different structural families. BPC-157 is a fifteen-residue synthetic peptide; TB-500 is a larger thymosin beta-4 related peptide.

Which molecular identifiers are verified for each?

Amino Fuel Labs records list a molecular weight of 1419.53 g/mol for BPC-157 and 4963.44 g/mol for TB-500, with the corresponding molecular formulas on each reference page.

Is either approved for human use?

No. Neither is an approved drug product. Both are supplied as research material only and are not for human or veterinary use.

How is identity confirmed for either compound?

Through the same analytical approach used across the catalog: chromatographic separation for purity and mass measurement for identity, reported per lot.

Research Comparison Reference

BPC-157 vs TB-500: Structural and Classification Comparison

A reference comparison of two structurally unrelated research peptides that are frequently discussed together in recovery-focused literature.

Attribute comparison

Verified attribute comparison for BPC-157 vs TB-500: Structural and Classification Comparison
Attribute	BPC-157	TB-500
Compound class	Synthetic pentadecapeptide	Synthetic thymosin beta-4 related peptide
Peptide or non-peptide	Peptide	Peptide
Amino-acid count	15	Not provided
Receptor or pathway classification	Not established	Actin-binding related pathways (preclinical)
Molecular weight	1419.53 g/mol	4963.44 g/mol
Physical form	Lyophilized powder	Lyophilized powder
Laboratory research context	In-vitro and animal tissue-repair models	In-vitro and animal cell-migration models
Available from Amino Fuel Labs	Yes	Yes

Key structural differences

BPC-157 is a short synthetic sequence of fifteen amino acids derived from a partial sequence reported in gastric juice. Its low molecular weight reflects that short chain.

TB-500 is a considerably larger molecule and is related to thymosin beta-4, a naturally occurring actin-sequestering protein. The two compounds are not analogs of each other and do not share a sequence family.

The practical consequence for laboratory work is that they are characterized differently. A fifteen-residue peptide and a molecule near five kilodaltons behave differently in chromatography, in mass analysis, and in solution.

Published research context

Both compounds have been investigated primarily in in-vitro systems and animal models. Neither is an approved drug product and neither has an established human indication.

Preliminary findings in animal models are not evidence of a human effect and are not presented here as such.

Frequently asked questions

Are BPC-157 and TB-500 chemically related?: No. They belong to different structural families. BPC-157 is a fifteen-residue synthetic peptide; TB-500 is a larger thymosin beta-4 related peptide.
Which molecular identifiers are verified for each?: Amino Fuel Labs records list a molecular weight of 1419.53 g/mol for BPC-157 and 4963.44 g/mol for TB-500, with the corresponding molecular formulas on each reference page.
Is either approved for human use?: No. Neither is an approved drug product. Both are supplied as research material only and are not for human or veterinary use.
How is identity confirmed for either compound?: Through the same analytical approach used across the catalog: chromatographic separation for purity and mass measurement for identity, reported per lot.

References

PubMed — BPC-157 preclinical literature — National Library of Medicine
PubMed — thymosin beta-4 literature — National Library of Medicine

Research use only. The information in this library is educational and is not medical advice. Products are not intended to diagnose, treat, cure, or prevent disease and are not for human or veterinary consumption.